文献速递儿科与产科急症消化、代谢与肾脏急症

肌注昂丹司琼对儿童肌注氯胺酮相关呕吐的影响:前瞻性随机双盲对照研究

Does intramuscular ondansetron have an effect on intramuscular ketamine-associated vomiting in children? A prospective, randomized, double blind, controlled study.
PubMed 文献 · Am J Emerg Med · 2019-09-12
一句话结论儿童急诊操作镇静中,肌注氯胺酮4 mg/kg联合昂丹司琼0.1 mg/kg较单用氯胺酮降低恢复期及离院前呕吐发生率。

这项前瞻性、随机、双盲、安慰剂对照、平行组临床试验在两家大学附属三级医院急诊科开展,纳入6月龄至16岁接受肌注氯胺酮操作镇静的儿童,比较肌注氯胺酮4 mg/kg(对照组65例)与氯胺酮4 mg/kg联合昂丹司琼0.1 mg/kg(干预组56例)的呕吐发生情况。干预组恢复期呕吐7例(12.5%)、离院前呕吐1例(1.8%),对照组分别为14例(21.5%)和6例(9.2%),两组差异均有统计学意义(P=0.03和P<0.001)。作者结论认为肌注昂丹司琼能有效控制氯胺酮相关呕吐。

要点

  • 在6月龄至16岁急诊操作镇静儿童中,肌注氯胺酮4 mg/kg联合昂丹司琼0.1 mg/kg较单用氯胺酮4 mg/kg降低恢复期呕吐(12.5% vs 21.5%,P=0.03)。
  • 联合昂丹司琼组离院前呕吐1例(1.8%),单用氯胺酮组6例(9.2%),差异有统计学意义(P<0.001)。
  • 样本为两家大学附属三级医院急诊科接受肌注氯胺酮操作镇静的儿童,采用方便抽样和区组随机(每区组4例)。
  • 作者结论认为肌注昂丹司琼能有效控制氯胺酮相关呕吐。

适用人群与场景

  • 6月龄至16岁在急诊科接受肌注氯胺酮操作镇静(PSA)的儿童;采用方便抽样,来自两家大学附属三级医院急诊科。

处置流程与药物剂量

  • 干预组肌注氯胺酮4 mg/kg联合昂丹司琼0.1 mg/kg;对照组肌注氯胺酮4 mg/kg。
  • 记录呕吐的发生及发生频率。

研究设计与关键结果

  • 前瞻性、随机、双盲、安慰剂对照、平行组临床试验,在两家大学附属三级医院急诊科开展,共56例接受昂丹司琼联合氯胺酮、65例接受单用氯胺酮。
  • 恢复期呕吐:昂丹司琼联合氯胺酮组7例(12.5%)vs 单用氯胺酮组14例(21.5%),P=0.03。
  • 离院前呕吐:昂丹司琼联合氯胺酮组1例(1.8%)vs 单用氯胺酮组6例(9.2%),P<0.001。

证据类型、等级与局限

  • 证据类型:前瞻性、随机、双盲、安慰剂对照、平行组临床试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为肌注昂丹司琼能有效控制氯胺酮相关呕吐,可考虑用于接受肌注氯胺酮操作镇静的6月龄至16岁儿童以减少恢复期及离院前呕吐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: This study was conducted to determine the effect of intramuscular ondansetron on ketamine-associated vomiting in children undergoing procedural sedation.

METHODS: This randomized, double-blind, placebo-controlled, parallel-group clinical trial was conducted at the emergency departments of two university-affiliated tertiary care hospitals. Eligible participants included all 6-month to 16-year-old children who received IM ketamine for PSA in the ED. A convenience sampling approach was used and a block randomization method was applied (blocks of four) using a computer-generated random sequence. Patients received ketamine 4 mg/kg or ketamine 4 mg/kg plus ondansetron 0.1 mg/kg intramuscularly. All findings including the occurrence of vomiting and its frequency were then recorded in the data collection sheets.

RESULTS: Of 56 patients who received ondansetron plus ketamin, 7 (12.5%) and 1 (1.8%) experienced vomiting during recovery and before discharge and Of 65 patients in the control group, 14 (21.5%) and 6 (9.2%) experienced vomiting during recovery and before discharge, respectively. The observed differences in the rates of vomiting during recovery and at discharge were statistically significant between the two groups (P-value of 0.03 and <0.001, respectively).

CONCLUSION: Intramuscular ondansetron is effective in controlling ketamine-associated vomiting.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Nejati A, Davarani SS, Talebian MT, et al. Does intramuscular ondansetron have an effect on intramuscular ketamine-associated vomiting in children? A prospective, randomized, double blind, controlled study. Am J Emerg Med. 2019. PMID: 31837906. doi:10.1016/j.ajem.2019.158445

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。